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e-mail address: dr_rgs@hotmail.com (R. Gonzalez-Salinas).Roberto Gonzalez-Salinas a,⇑; Fabiola Pena-Guani bAbstractThe objective of this article was to determine the long-term outcome of surgical treatment in a patient with bilateral congenital
aniridia and congenital cataracts. The patient was treated by cataract removal and implantation of a single piece IOL in both eyes.
Two aniridia rings were also implanted in the capsular bag. The best-corrected visual acuity (BCVA), intraocular pressure (IOP),
stability of the intraocular lens (IOL) and subjective glare reduction were measured for two years after the surgery. After
10 months, the IOP in the left eye had increased to 26 mmHg despite the fact that anti-glaucoma medication was added. There-
fore, the patient was scheduled for an Ahmed valve implantation. These results suggest that good visual outcomes can be
achieved in patients with bilateral congenital aniridia and cataracts. Nevertheless, the IOPs must be continuously monitored,
and glaucoma screening performed to prevent further complications.
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Bilateral congenital aniridia is a rare disorder and is char-
acterized by a partial or total absence of the iris associated
with foveal hypoplasia which leads to a reduction of the visual
acuity and nystagmus from an early age.1 The prevalence of
congenital aniridia is 1:64,000–1:96,000, and higher rates
have been reported in patients who are younger than
20 years (1:47,000).2 Congenital aniridia is associated with
defects of the cornea, anterior chamber, iris, lens, retina,
macula, and the optic nerve. Approximately, 85% of
individuals with aniridia inherit it as an autosomal dominant
trait and 13% as part of the autosomal-dominant WAGRsyndrome characterized by Wilms’ tumor, aniridia, genitouri-
nary abnormalities, and mental retardation. The remaining
patients are associated with other syndromes such as Gille-
spie syndrome and Peters anomaly.3 Mutations or intragenic
deletions of the PAX6 gene represent the major causes of
aniridia.4
Abnormalities frequently associated with aniridia include
cataracts, glaucoma, and opacifications of the cornea.5 Ker-
atopathy develops secondary to limbal stem-cell deficiency
and is believed to have an incidence of about 20%. Aniridia
associated with glaucoma has a reported incidence of 6 to
75% with 91% of these primarily due to angle and trabecular
developmental abnormalities. These patients respond poorlye:
al.com
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cological therapy, and these patients require frequent
glaucoma surgery to achieve an adequate control of the
intraocular pressure (IOP).5–7
Congenital aniridia is associated with cataracts in 50–85%
of patients.5 Lens opacities combined with the lack of the
irides result in glare, photophobia, and reduced visual acuity.
However, cataract extraction presents significant technical
challenges including reduced visibility of the intraocular
structures due to corneal opacities and fragile anterior lens
capsule due to a significant thinning of the capsule.8 This
fragility may cause tears in the anterior capsular either during
capsulorhexis or by subsequent manipulations. Such compli-
cations may require significant alterations of the surgical plan
because intraocular lenses and iris prosthetic devices require
an intact capsular bag.9
Among the options for prosthetic restoration of the irides
are devices which allow the implantation of Morcher aniridia
rings through an incision of about 3 mm. The aniridia rings
are capsular tension rings with multiple fins separated by
the same size spaces. Two such rings are implanted into
the capsular bag and placed in such a way that the fins of
one ring overlap the spaces of the other.10 Combined pha-
coemulsification cataract extraction with an implantation of
a foldable intraocular lens and aniridia rings placement have
been shown to be particularly effective in reducing glare and
photophobia in patients with aniridia and albinsm.10,11 We
present our findings in a patient with bilateral congenital anir-
idia who was successfully treated with an implantation of an
IOL and aniridia rings.
Case report
A 26-year-old man presented with complaints of a pro-
gressive decrease in his vision and glare in both eyes of
8 months duration. His medical history revealed that his
father was diagnosed with open angle glaucoma. The
patient’s best-corrected visual acuity (BCVA) was 1.0 logMAR
units in both eyes. Horizontal pendular nystagmus was pre-
sent in both eyes. The IOP measured by Goldmann applana-
tion tonometry was 12 mmHg OD and 14 mmHg OS.
Slit-lamp examination of the right eye showed a 360
peripheral corneal vascular proliferation, inferior corneal leu-
coma, superficial punctate keratitis demonstrated by diffuse
epithelial staining of the central cornea with fluorescein, total
aniridia, and a NO2NC2 cataract according to the Lens
Opacities Classification System II (LOCS II).12 Slit-lamp
examinations of his left eye showed a 300 peripheral cornealFig. 1. Slit-lamp photographs of the right and left eyes showing 300 periphe
aniridia, and cataracts.vascular proliferation, mild superficial punctate keratitis, total
aniridia, and a NO2NC2 cataract (Fig. 1). A fundus examina-
tion revealed absence of macular reflex and a normal optic
disk in both eyes. Specular microscopy showed an endothe-
lial cell density of 3289 for the right eye and 2906 cells/
mm2 for the left eye.
Small incision (2.2 mm) phacoemulsification was per-
formed with an implantation of an acrylic foldable intraocular
lens (Alcon Laboratories, Inc., Fort Worth, TX, USA). Addi-
tionally, a Morcher type 50C endocapsular aniridia ring was
placed (Morcher Type, Morcher Company, Germany), and
both the IOL and the aniridia rings were inserted in the cap-
sular bag in both eyes by the same surgeon with an interval of
two weeks.
After two months, the BCVA improved to 0.89 logMAR
units in both eyes with no signs of inflammation, and the
BCVA in the right eye improved to 0.69 logMAR units at
the 6 months visit; additionally, a subjective mild improve-
ment in glare perception was referred (Fig. 2).
At the 10th month visit, the patient complained of
decreased vision in the left eye (1.3 logMAR units) and was
found to have an elevation of the IOP to 26 mmHg. There
was also a displacement of one of the rings due to capsular
fibrosis and contraction without IOL displacement (Fig. 3).
Combined topical dorzolamide and timolol treatment was
initiated in the left eye, and at the one year follow-up, the
IOP was not significantly decreased despite the fact that a
third anti-glaucoma medication was added. Therefore, the
patient was treated with an implantation of an Ahmed glau-
coma valve in the superotemporal quadrant and the removal
of the displaced ring.
Six months later, the BCVA was 0.92 logMAR in the right
eye, and the IOP in the left eye was maintained at 14 mmHg
with topical timolol.
Discussion
Cataract is found in 50–85% of the patients with congeni-
tal aniridia. Phacoemulsification cataract extraction in
patients with aniridia will improve in the BCVA8–10; nonethe-
less, the surgical procedure is often challenging due to
abnormalities associated with congenital aniridia, including
shallow chamber, corneal leucoma and limited visualization.
In addition, the outcome can be limited by a worsening of
the keratopathy or the development of glaucoma in more
than 50% of the cases.13 Recent studies have demonstrated
a significant association of intraocular surgery and progres-
sion of corneal opacities. Moreover, Reinhard et al.,14ral corneal vascular proliferation, mild superficial punctate keratitis, total
Fig. 2. Slit-lamp photographs of both eyes. A. Slit-lamp examination of the left eye showing no signs of inflammatory disease two months after the
surgical procedures. B. Slit-lamp photograph showing the red reflex of the left eye, with no ring misalignment present.
Fig. 3. Slit-lamp photograph of the left eye showing a displacement of
one of the rings due to capsular fibrosis without displacement of the
intraocular lens.
66 R. Gonzalez-Salinas, F. Pena-Guanireported postoperative uveitis, secondary glaucoma, clini-
cally significant macular edema, chronic endothelial cell loss,
progression of corneal epithelial disorders, and hyphema.
Cataract extraction with IOL implantation can lead to further
damage of the limbal stem cells which can cause a permanent
deficiency for recovery.
Likewise, Burk et al.,15 in a 28 patient series of prosthetic
iris implantation for congenital, traumatic, and functional iris
deficiencies, of which 10 eyes had congenital aniridia,
reported incomplete capsulorhexis, transient hypotony, per-
sistent inflammation and glaucoma therapy addition among
patients with elevated IOP after the surgical procedure, fur-
thermore, described two capsulorhexis tores while implant-
ing 50C rings due to the fragility of the anterior capsules in
eyes with congenital aniridia; which made the rings mobile
during the surgical procedure.
In our case, the occurrence of displacement of the iris
implant due to a contraction of the capsular bag 10 months
after the surgical procedure, leads to persistent inflamma-
tion, and constant rise in IOP measurements, which required
removal of one of the rings with glaucoma valve surgery in
the late post-operative period. Similarly, Gerreiro et al.,16
described a contraction of the capsular bag, 8 months
after cataract phacoemulsification and aniridic ring implan-
tation (Morcher Aniridia rings 50 D) a patient withAxenfeld-Rieger syndrome. UBM examination showed con-
traction of the capsular bag, which appeared wrinkled,
fibrous, and thickened. The capsular bag comprised the
aniridic ring fins, causing misalignment. After 8 months, the
glare disability had dropped from grade 0 to 3. This outcome
strongly suggests that capsular bag shrinking caused migra-
tion of the aniridic rings, 8 months after surgery.Conclusion
Combined phacoemulsification cataract extraction with
foldable IOL implantation and aniridia rings placement
suggests that good visual outcomes can be achieved in
patients with bilateral congenital aniridia and cataract.
Glaucoma assessment should be performed in all aniridia
patients who undergo phacoemulsification cataract extrac-
tion; in addition, IOP levels must be evaluated frequently,
including an optic disk examination. Refractory cases may
require glaucoma filtering surgery.Financial disclosure
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